CAGAS
SYRS

Capital Advisory Group Advisory Services’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-70
Closed -$4K – 590
2021
Q2 		$4K Buy
+70
New +$4K ﹤0.01% 483